ESPERAS PHARMA
Esperas Pharma is a special purpose company created to develop one compound to proof-of-concept.
ESPERAS PHARMA
Social Links:
Founded:
2015-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Total Employee:
1+
Status:
Active
Total Funding:
0
Similar Organizations
AurKa Pharma
AurKa Pharma Inc. is a special purpose company created to develop one compound to proof-of-concept.
BioLoomics
BioLoomics is a preclinical stage biotechnology company that develops drug discovery tools and protein drugs.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Investors List
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Venture Round - Esperas Pharma
TVM Capital Life Science
TVM Capital Life Science investment in Venture Round - Esperas Pharma
More informations about "Esperas Pharma"
Esperas Pharma Inc. will begin clinical development of …
Apr 11, 2016 Esperas Pharma Inc. is funded by TVM Life Science Ventures VII and the Fonds. Esperas is led by an experienced management team. About …See details»
Esperas Pharma - Crunchbase Company Profile & Funding
Esperas Pharma is a special purpose company created to develop one compound to proof-of-concept.See details»
Esperas Pharma Inc. - TVM Capital Life Science Venture …
Esperas Pharma Inc., Montréal, is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM Life Science Innovation I L.P. and Fonds de solidarité FTQ.See details»
Esperas Pharma, Inc. Announces Investment from TVM Life
Feb 21, 2023 Esperas Pharma, Inc. is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM Life Science Innovation I …See details»
ESPERAS PHARMA INC. | Canada Corporation Directory
ESPERAS PHARMA INC. is a Non-distributing corporation with 50 or fewer shareholders corporation type, which located at 1255 UNIVERSITY, #1610 MONTREAL QC H3B 3X3 Canada.See details»
Esperas Pharma, Inc. Announces Investment from TVM Life Science ...
Feb 21, 2023 Esperas Pharma, Inc. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM Capital Life Science (“TVM”) through its fund TVM …See details»
Esperas Pharma 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Esperas Pharma. Use the PitchBook Platform to explore the full profile.See details»
Esperas Pharma, Inc. Announces Investment from TVM Life Science ...
Feb 21, 2023 Esperas Pharma, Inc., a company based in Montréal, Québec, announced a follow-on investment by TVM Capital Life Science through its fund TVM Life Science …See details»
Esperas Pharma Inc. Company Profile | Montréal, QC, Canada ...
Find company research, competitor information, contact details & financial data for Esperas Pharma Inc. of Montréal, QC. Get the latest business insights from Dun & Bradstreet.See details»
Esperas Pharma Inc. will begin clinical development of a new anti ...
Apr 14, 2016 Montréal, Québec, April 11 2016 – Esperas Pharma Inc. (“Esperas”) today announced the initiation of a project to develop a new oral anticancer agent called ESP-01, in …See details»
In partnership with Q-CROC, Esperas will invest up to $7M in a …
MONTREAL, April 11, 2016 /CNW Telbec/ – Esperas Pharma Inc. (“Esperas”) today announced the initiation of a project to develop a new oral anticancer agent called ESP-01, in partnership …See details»
Esperas Pharma Inc. - Drug pipelines, Patents, Clinical trials
Explore Esperas Pharma Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 1 news, and 3 literature, Disease Domain:Endocrinology and Metabolic Disease, …See details»
New anti-cancer agent to be commercialized in Quebec partnership
Apr 12, 2016 Montreal, QC – Esperas Pharma is partnering with Quebec Clinical Research Organization in Cancer (Q-CROC) in a project to develop a new oral anticancer agent called …See details»
Esperas Pharma, Inc. Announces Investment from TVM Life Science ...
MONTRÉAL, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Esperas Pharma, Inc. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM …See details»
Organization | Esperas Pharma Inc.
Esperas Pharma Inc. Report issue For profit Phase 2 Founded: Montreal Canada (2015) Status: Defunct (2021) Organization Overview First Clinical TrialSee details»
Esperas Pharma - Funding, Financials, Valuation & Investors
Apr 13, 2015 Esperas Pharma is a special purpose company created to develop one compound to proof-of-concept.See details»
Esperas Pharma, Inc. Announces Investment from TVM Life Science ...
Feb 21, 2023 About Esperas Pharma, Inc. Esperas Pharma, Inc. is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM …See details»
Esperas Pharma - Products, Competitors, Financials, Employees ...
About Esperas Pharma Esperas Pharma is a special-purpose company created to develop one compound for proof-of-concept. The company develops medical science and research and …See details»
Psychopharmaceuticals: 50 years of stagnation? | Health | EL PAÍS …
1 day ago Psychopharmaceuticals: 50 years of stagnation? While treatments for cancer and heart disease have advanced in leaps and bounds, psychiatry continues to use the drugs that …See details»
Esperas Pharma Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jun 13, 2023 Explore Esperas Pharma Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news.See details»